Managing HPV: A New Era in Patient Care – HPV

The Association of Reproductive Health Professionals (ARHP) and Planned Parenthood®  Federation of America (PPFA) partneredon a comprehensive clinical education program, Managing HPV: A New Era in Patient Care. In tandem with the American Society for Colposcopy …

The Association of Reproductive Health Professionals (ARHP) and Planned Parenthood®  Federation of America (PPFA) partneredon a comprehensive clinical education program, Managing HPV: A New Era in Patient Care. In tandem with the American Society for Colposcopy and Cervical Pathology (ASCCP), this program addresses current research and best practice recommendations concerning HPV testing, incorporating the HPV vaccine into prevention care, and treatment for complications of HPV including external genital warts and cervical cancer.

For more information about the program, please contact charris@arhp.org or (202) 466-3825.

Background

Despite being the most prevalent sexually transmitted infection (STI) in the United States, the majority of American men and women are unfamiliar with human papillomavirus (HPV).1 As a result, most people are unaware of the link between HPV and cervical cancer. The importance of educating the public about this connection is a frontline issue for the reproductive health care community. Clinicians recognize the importance of providing clients with the most recent developments in the fight against cervical cancer including the introduction of improved screening tools for HPV and the development of the HPV vaccine. ARHP and PPFA are committed to providing health care practitioners with progressive, medically-accurate information and advanced prevention, screening, and treatment options for HPV and cervical cancer.

Program Components

  • Literature review, needs assessment report, and clinical recommendations
  • Curriculum with talking points and case studies , developed by an expert medical advisory committee
  • Integration of content into CORE, ARHP’s on-line, open-access collection of peer-reviewed, evidence-based teaching materials
  • Archived webinars
  • Patient education fact sheets Making Sense of Cervical CancerUnderstanding the HPV Vaccine and Understanding Cervical Cancer Screening Test Results
  • Quick Reference Guide for Clinicians Managing HPV: A New Era in Patient Care
  • Mobile CME Activities
  • Navigating HPV, an online interactive Web tool for parents and young people seeking information on HPV prevention

Curriculum Learning Objectives

  • Describe the significance of infection with HPV to patients including prevalence, mode of transmission, and long-term consequences
  • Utilize national guidelines when screening patients for cervical and anal disease
  • Apply evidence-based guidelines when managing women with abnormal screening tests
  • Counsel patients regarding potential benefits and risks of vaccination against HPV

Intended Audience and Accreditation

The intended audience for the medical education activities is health care professionals—physicians, nurse practitioners, physician assistants, nurse midwives, pharmacists, researchers and others in the fields of ob/gyn and family practice. The public education activities have been developed for patients, the media, and the public.

The curriculum/live sessions, webinars, MobileCME, and Clinical Proceedings associated with this program are accredited for continuing medical education, nursing contact hours, pharmacology, and pharmacist credits.

Funding

This project is funded through independent education grants from a collaboration of pharmaceutical companies including GlaxoSmithKline, Graceway Pharmaceuticals, Merck and Co. Inc., and QIAGEN.

Reference

  1. Anhang R, Goodman A, Goldie SJ. HPV Communication: Review of Existing Research and Recommendations for Patient Education. CA Cancer J Clin. 2004;54;248-259.
Drug Integrity Associate Audrey Amos is a pharmacist with experience in health communication and has a passion for making health information accessible. She received her Doctor of Pharmacy degree from Butler University. As a Drug Integrity Associate, she audits drug content, addresses drug-related queries

Leave a Comment

error: Content is protected !!